EUCTR2011-005643-26-IT进行中（未招募）不适用
Cross-over pharmacokinetic study and pharmacodynamics of 2 different folate (5-MTHF and folic acid) in patients with liver cirrhosis with viral etiology. A randomized, open-label trial. - PrefoCir2
ZAMBON ITALIA0 个研究点开始时间: 2012年3月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with confirmed diagnosis of liver cirrhosis with viral etiology Age between 18 and 70 years Consent to participate in the study and willingness to submit to visits by the Protocol
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •Women who are pregnant or lactating Presence of cancer at enrollment or within five years preceding Presence of gastrointestinal bleeding or episodes that occurred in the four weeks prior to enrollment transplant patients Patients who have ongoing treatment with immunosuppressive or interferon Patients with a BMI more than 30 or less than 18 Patients in chronic therapy with folate, or medications / supplements containing B vitamins
研究者
相似试验
招募中
3 期
A Randomized, Crossover, Pharmacokinetic and Pharmacodynamic Study to Determine the Safety and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103), Compared to Cystagon® in Patients with Nephropathic Cystinosismetabolic disorder in which the transport of cystine out of the lysosomes is abnormalNephropathic cystinosis10000546NL-OMON34074Raptor Pharmaceuticals Europe BV5
进行中（未招募）
1 期
A Randomized, Crossover, Pharmacokinetic and PharmacodynamicStudy to Determine the Safety and Efficacy of Cysteamine BitartrateDelayed-release Capsules (RP103), Compared to Cystagon® in Patientswith Nephropathic CystinosisCystinosisEUCTR2009-017882-42-FRRaptor Therapeutics Inc.
进行中（未招募）
不适用
A Randomized, Crossover, Pharmacokinetic and PharmacodynamicStudy to Determine the Safety and Efficacy of Cysteamine BitartrateDelayed-release Capsules (RP103), Compared to Cystagon® in Patientswith Nephropathic CystinosisMedDRA version: 12.1Level: LLTClassification code 10011777Term: CystinosisCystinosisEUCTR2009-017882-42-NLRaptor Therapeutics Inc.20
已完成
不适用
Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukaemia (ALL)CancerISRCTN75734403Medac GmbH (Germany)32
已完成
4 期
A study on pharmacokinetics (fate of drug in the body) of single oral dose of 15mg and 45 mg Primaquine in healthy human volunteersCTRI/2011/06/001803I12